Kicking RCC in the GLUT

  title={Kicking RCC in the GLUT},
  author={Tim Fulmer},
A Stanford team has identified a compound that blocked growth of renal cell carcinomas in mice by inhibiting a metabolic pathway unique to the tumors. The GLUT1 inhibitor has been exclusively licensed by Ruga Corp., which is optimizing the compound and hopes to be in the clinic next year. 

Topics from this paper.

Similar Papers